Tiziana life sciences announces collaboration with parexel biotech to conduct phase 1b/2 clinical trial in patients with crohn's disease

First ever study with take-home capsules of foralumab , a fully human anti-cd3 monoclonal antibody
TLSA Ratings Summary
TLSA Quant Ranking